✦ LIBER ✦

Marked thrombocytosis during treatment with ceftazidime for pulmonary infection

✍ Scribed by Chen, Huang-Chi ;Wang, Cheng-Yuan ;Wang, Chuan-Sheng

Book ID: 106494656
Publisher: Springer
Year: 2007
Tongue: Dutch
Weight: 124 KB
Volume: 30
Category: Article
ISSN: 1573-739X
DOI: 10.1007/s11096-007-9145-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ceftazidime with or without amikacin for

Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile, granulocytopenic patients

✍ I. R. O. Nováková; J. P. Donnelly; B. E. de Pauw 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 556 KB

Cutaneous, pulmonary and hepatic sarcoid

Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon-alpha treatment for hepatitis C virus infection

✍ BN Akay; P Ekmekci; H Sanli; G Celik; M Bozdayi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Stenotrophomonas maltophilia Infection d

Stenotrophomonas maltophilia Infection during Treatment for Pancreatitis with Imipenem/Cilastatin

✍ Shobha Sharma; Tanyanyiwa Chinyadza; Edward K. Chapnick; Monica Ghitan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Emergence of linezolid-resistant Staphyl

Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis

✍ Ana C. Gales; Hélio S. Sader; Soraya S. Andrade; Larissa Lutz; Adão Machado; Afo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Risk factors for infection during treatm

Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C

✍ Robert Roomer; Bettina E. Hansen; Harry L. A. Janssen; Robert J. de Knegt 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

Neutropenia during treatment with peginterferon alfa and ribavirin for chronic hepatitis C virus (HCV) infection is a common cause of dose reductions of peginterferon alfa. These reductions are performed to prevent bacterial and fungal infections, which are common during HCV treatment and can be att

IRREVERSIBLE ALOPECIA UNIVERSALIS DURING

IRREVERSIBLE ALOPECIA UNIVERSALIS DURING TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR CHRONIC HCV INFECTION

✍ B. Omazzi; G. Borroni; A. Bortoli; A. Prada 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB